Effects of Laughter Therapy on Postpartum Mothers' Stress, Sleep, and Breastfeeding
Launched by SELCUK UNIVERSITY · Feb 27, 2025
Trial Information
Current as of July 23, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The postnatal period is an important developmental transition period for women and mothers experience various difficulties. Therefore, midwives are expected to assess women and identify women in need of supportive interventions and consciously contribute to their treatment. Previous studies reflect mothers' desire for non-pharmacological therapies and a high degree of satisfaction with these therapies. Laughter therapy, one of the main non-pharmacological interventions, is recognised as a universal approach to reduce stress and anxiety. Laughter therapy is a new, simple, cost-effective, non...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • At least primary school graduate
- • Over the age of 18
- • Those who volunteer to participate in the research
- • Heterosexual
- • Having a single and healthy baby
- • Postpartum 1-12 month old baby
- • Women who can use Zoom program
- Exclusion Criteria:
- • Those who do not speak Turkish,
- • Those with hearing and visual impairments,
- • Those with mental disabilities,
- • Those diagnosed with a known psychiatric disease,
- • Mothers who do not breastfeed
- • Mothers who have babies with disabilities and chronic health problems
- • Women with physical conditions that prevent them from participating in laughter yoga sessions (respiratory distress, persistent cough, vertiligo, severe heart disease, hemorrhoids, any type of hernia such as neck, waist or inguinal hernia, severe back pain, urinary incontinence, epilepsy, etc.),
- • Women who use medication or use another non-pharmacological method to reduce stress.
- • Women who develop an acute health problem in themselves or their babies, who have a sudden hospitalisation of the mother or baby, mothers who lose their babies, women who do not attend all of the laughter therapy sessions and women who cannot be reached after the application will be excluded from the study.
About Selcuk University
Selçuk University is a prominent educational institution located in Turkey, recognized for its commitment to advancing medical research and clinical studies. As a clinical trial sponsor, Selçuk University leverages its extensive academic resources and expertise to conduct innovative research that aims to address significant healthcare challenges. The university fosters collaboration among researchers, healthcare professionals, and industry partners to facilitate the development of new therapies and improve patient outcomes. Through rigorous adherence to ethical standards and regulatory guidelines, Selçuk University strives to contribute to scientific knowledge and enhance the quality of care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Konya, Selçuklu, Turkey
Konya, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported